A Multi-Pronged Computational Pipeline for Prioritizing Drug Target Strategies for Latent Tuberculosis.

Area of Science:

• Bioinformatics and computational biology
• Infectious disease research
• Drug discovery and development

Background:

• Latent tuberculosis, caused by dormant Mycobacterium tuberculosis (Mtb), is a major obstacle to global eradication efforts.
• Current anti-tubercular drugs are ineffective against the dormant Mtb form, leading to low treatment adherence due to prolonged therapy.
• Developing new drugs targeting latent tuberculosis is crucial for effective disease control.

Purpose of the Study:

• To identify novel drug targets and lead candidates against latent tuberculosis using integrated bioinformatics and chemoinformatics approaches.
• To explore new therapeutic strategies for combating dormant Mtb infections.
• To provide lead compounds for the design of new anti-tubercular drugs.

Main Methods:

• Utilized transcriptome-integrated metabolic flux analysis to identify Mtb perturbations in dormant states.
• Analyzed transcriptome-integrated protein-protein interaction networks to pinpoint potential drug targets.
• Employed structural modeling, binding site analysis, and ligand fingerprint similarity for lead compound identification.

Main Results:

• Shortlisted 6 potential drug targets against dormant Mtb through network and flux analysis.
• Identified lead compounds for 3 selected drug targets using various bioinformatics techniques.
• Established new strategies and targets for latent tuberculosis treatment.

Conclusions:

• The study successfully identified promising drug targets and lead compounds for latent tuberculosis.
• The employed computational pipeline offers a novel approach for discovering anti-tubercular therapeutics.
• Findings provide crucial insights for designing new drugs to combat dormant Mtb infections.